MedPath

Kathryn O'Connor

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression

Completed
Conditions
Treatment Resistant Depression
Interventions
Drug: Monoamine Oxidase Inhibitor (MAOI)
First Posted Date
2017-04-12
Last Posted Date
2021-06-18
Lead Sponsor
Kathryn O'Connor
Target Recruit Count
11
Registration Number
NCT03109717
Locations
🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath